For the safety of our patients and staff, we now request that all visitors to MSK are fully vaccinated against COVID-19. Read the latest information for visitors.
Developing New Treatments for T Cell Lymphoma
Share
Print
VIDEO | 05:00
Medical oncologist Steven M. Horwitz discusses the development and impact of three new, widely used therapies for T cell lymphoma: pralatrexate, romidepsin, and brentuximab vedotin.